Calif. pain relief device firm obtains $48M in funding round

03/8/2013 | American City Business Journals

A round of Series C financing headed by Novo Ventures has pulled in $48 million for Nevro. The Menlo Park, Calif.-based company, which focuses on a device to treat chronic back pain, will use the money to finance its product development and commercialization, CEO Michael Demane said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT